Breakdown | |||||
TTM | Jan 2024 | Apr 2023 | Jan 2023 | Jan 2022 | Jan 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
93.95B | ― | ― | ― | ― | ― | Gross Profit |
20.74B | 20.87B | 5.02B | 22.69B | 21.89B | 76.57B | EBIT |
5.67B | 5.21B | 1.07B | 5.77B | 4.66B | 3.69B | EBITDA |
5.54B | 8.69B | 1.11B | 7.60B | 12.02B | 9.79B | Net Income Common Stockholders |
4.09B | 3.21B | 583.00M | 2.44B | 5.56B | 3.25B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
― | ― | ― | ― | ― | ― | Total Assets |
82.09B | 82.09B | 84.09B | 89.61B | 92.73B | 123.42B | Total Debt |
25.99B | 25.99B | 28.43B | 29.59B | 26.95B | 39.22B | Net Debt |
18.63B | 18.63B | 20.80B | 20.98B | 17.48B | 29.71B | Total Liabilities |
84.40B | 84.40B | 87.02B | 92.64B | 94.31B | 120.94B | Stockholders Equity |
― | ― | ― | ― | ― | ― |
Cash Flow | Free Cash Flow | ||||
2.83B | 5.92B | 1.08B | 562.00M | 7.51B | 9.32B | Operating Cash Flow |
5.47B | 8.68B | 1.78B | 3.56B | 10.31B | 11.41B | Investing Cash Flow |
-2.21B | ― | ― | ― | ― | ― | Financing Cash Flow |
-6.24B | ― | ― | ― | ― | ― |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $2.89T | 31.30 | 30.64% | 0.80% | 15.04% | 12.38% | |
76 Outperform | $3.54T | 37.51 | 144.03% | 0.53% | 2.61% | -2.14% | |
72 Outperform | $24.74B | 9.86 | 10.29% | 2.73% | 3.30% | 25.00% | |
67 Neutral | $234.79B | 39.40 | 22.06% | 2.65% | 1.45% | -20.56% | |
66 Neutral | $66.01B | 14.74 | -179.12% | 1.86% | 7.99% | ― | |
61 Neutral | $29.11B | 11.09 | 84.33% | 3.71% | 1.03% | -18.56% | |
59 Neutral | $22.39B | 11.53 | -18.05% | 2.31% | 5.00% | -25.89% |